FDA Drug recall D-0480-2017
METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL…
- FDA Drug
- Class II
- terminated
- Published 2017-03-01
On 2017-03-01 the FDA classified a Class II recall of METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL… by Hospira A Pfizer, citing lack of Sterility Assurance: customer report of leaking bag.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0480-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-02-10 |
| Published | 2017-03-01 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira A Pfizer |
| Distribution | US |
Product
METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24
Reason
Lack of Sterility Assurance: customer report of leaking bag
Identifiers
| code_info | Lot: 54-054-JT, 6/1/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0480-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.